Back
GSK PLC Quote, Financials, Valuation and Earnings
Sponsored
GSK
Sponsored
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
29
GSK
GSK PLC
Last Price:
$33.61
Seasonality Move:
4.52%
7 Day Trial
ALL ACCESS PASS
$
7
Elon Musk Predicts MAJOR Crisis in Trump's First Year
See Why Investors are Pouring Mountains of Cash into Certain Companies Trump Wants to Solve the Problem.GSK PLC Price Quote
$33.61
+0.01 (+0.54%)
(Updated: December 21, 2024 at 5:29 AM ET)
GSK PLC Key Stats
Sell
29
GSK PLC (GSK)
is a Sell
Day range:
$33.04 - $33.87
52-week range:
$32.83 - $45.93
Dividend yield:
4.66%
P/E ratio:
11.26
P/S ratio:
1.74
P/B ratio:
3.66%
Volume:
6.8M
Avg. volume:
5.6M
1-year change:
-7.16%
Market cap:
$68.6B
Revenue:
$37.7B
EPS:
$1.54
How Much Does GSK PLC Make?
Data Unavailable
Is GSK PLC Growing As A Company?
Data Unavailable
GSK PLC Stock Price Performance
What Is GSK PLC 52-Week High & Low?
GSK PLC Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy GSK PLC?
Data Unavailable
Is GSK PLC Cash Flow Positive?
Data Unavailable
GSK PLC Return On Invested Capital
Data Unavailable
GSK PLC Earnings Date & Stock Price
-
What Is GSK PLC's Stock Price Today?A single share of GSK can be purchased today for 33.60
-
What Is GSK PLC’s Stock Symbol?
-
When Is GSK PLC’s Next Earnings Date?The next quarterly earnings date for GSK PLC is scheduled on February 5, 2025
-
When Is GSK's next ex-dividend date?GSK PLC's next ex-dividend date is November 15, 2024
-
How To Buy GSK PLC Stock?You can buy GSK PLC shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
GSK PLC Competitors
GSK PLC Dividend Yield
Data Unavailable
GSK PLC Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | -27.64% | 10.97% |
Revenue: | 1.06% | 0.5% |
Analyst Recommendations
Buy Recommendations: | 2 |
---|---|
Hold Recommendations: | 4 |
Sell Recommendations: | 0 |
Price Target: | 42.93 |
Upside from Last Price: | 27.77% |
Major Shareholders
Data Unavailable